Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year
As Attenua continues to develop its lead program for chronic cough, it will be doing so with $35 million in the bank and under the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
